Company / Current Assets per Share
Vir Biotechnology, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$3.75
FY2025
5-year range
$3.75 / $19.21
FY2021-FY2025
Trend
-51.5%
vs FY2024
Sector context
#150 of 210
Health Care
What the data says
At $3.75, Vir Biotechnology, Inc.'s current assets per share ranks #150 of 210 in the Health Care sector. Current Assets per Share has declined for 3 consecutive years, from $19.21 in FY2022 to $3.75 in FY2025.
Based on SEC 10-K filings.
3.75 in FY2025 with a 5-year CAGR of -12.2%.
Declined from $11.92 to $3.75 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -42.0%
- 5-Year CAGR
- -12.2%
- 10-Year CAGR
- -
Sector benchmark
#150 of 210 in Health CareTop 71% of 210This company $3.75 Sector average $170.65
▼
-97.8% below sector average
Key checks
Key Insights
- Vir Biotechnology, Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 51.5% year-over-year.
- Ranks #150 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.75 | -51.5% |
| FY2024 | $7.73 | -35.1% |
| FY2023 | $11.92 | -37.9% |
| FY2022 | $19.21 | +56.6% |
| FY2021 | $12.27 | +71.0% |
| FY2020 | $7.17 | -84.2% |
| FY2019 | $45.49 | +196.1% |
| FY2018 | $15.36 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026